Article
In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand.
Antimicrobial agents and chemotherapy - 1 Jan 2018
Leechawengwongs Manoon, Prammananan Therdsak, Jaitrong Sarinya, Billamas Pamaree, Makhao Nampueng, Thamnongdee Nongnard, Thanormchat Arirat, Phurattanakornkul Arisa, Rattanarangsee Somcharn, Ratanajaraya Chate, Disratthakit Areeya, Chaiprasert Angkana
Abstract excerpt
New fluoroquinolones (FQs) have been shown to be more active against drug-resistant Mycobacterium tuberculosis strains than early FQs, such as ofloxacin. Sitafloxacin (STFX) is a new fluoroquinolone with in vitro activity against a broad range of bacteria, including M. tuberculosis This study aimed to determine the in vitro activity of STFX against all groups of drug-resistant strains, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
